
Dmitry Nevozhay, M.D., Ph.D.
Department of Imaging Physics, Division of Diagnostic Imaging
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
2006 | Institute of Immunology and Experimental Therapy, Warsaw, PL, Experimental Oncology, Ph.D |
2002 | Vladivostok State Medical University, Vladivostok, RU, Medicine, M.D |
Experience & Service
Administrative Appointments/Responsibilities
Co-Director of Faculty Development, Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
Other Appointments/Responsibilities
Visiting Scientist, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 2016 - 2017
Institutional Committee Activities
Member, Residency Recruitment Committee / Imaging Physics, 2023 - Present
Member, Faculty Recognition Program and Merit Committee / Imaging Physics, 2022 - Present
Member, Culture of Safety Survey Committee / Imaging Physics, 2022 - Present
Honors & Awards
2011 | Young Researcher Travel Award, Synthetic Biology 5.0 Conference, Stanford University, USA |
2010 | Best Poster Award, From Networks to Pattern Formation Symposium, Rice University |
2009 | AMGEN Award in Basic Science Research, UT MDACC |
2008 | Second Prize Poster Award, Systems Biology of Cancer Conference, UT MDACC |
2007 | Postdoctoral Fellowship, Jozef Mianowski Fund and Foundation for Polish Science. Warsaw Poland |
2006 | Ph.D. with Honors, Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland |
2005 | The Best Scientific Work Award, The Vth Conference of Young Scientists / The VIth Russian Oncological Congress |
2005 - 2007 | Travel grants, NDDO Research Foundation, Amsterdam, The Netherlands |
2005 | Travel grant, European School of Hematology, Paris, France |
2002 - 2006 | Ph.D. Scholarship, Polish Ministry of Science and Education, Poland |
Selected Publications
Peer-Reviewed Articles
- Nevozhay, D, Rauch, R, Wang, Z, Sokolov, KV. Optimal size and PEG coating of gold nanoparticles for prolonged blood circulation. Nanoscale Advances 7(3):722-727, 2025. e-Pub 2025. PMID: 39811023.
- Mendieta M, Hatami M, Singh M, Fard SS, Dehshiri M, Schill A, Nevozhay D, Aglyamov S, Ozpolat B, Sokolov KV, Akay YM, Larin KV, Akay M. Non-invasive measurement of elasticity in glioblastoma multiforme validates decreased TMZ sensitivity in astrocyte co-culture. IEEE Open J Eng Med Biol, 2025. e-Pub 2025.
- Sehl OC, Yang Y, Anjier AR, Nevozhay D, Cheng D, Guo K, Fellows B, Mohtasebzadeh AR, Mason EE, Sanders T, Kim P, Trease D, Koul D, Goodwill PW, Sokolov K, Wintermark M, Gordon N, Greve JM, Gopalakrishnan V. Preclinical and Clinical-Scale Magnetic Particle Imaging of Natural Killer Cells: in vitro and ex vivo Demonstration of Cellular Sensitivity, Resolution, and Quantification. Mol Imaging Biol 27(1):78-88, 2024. e-Pub 2024. PMID: 39653984.
- Hatami M, Nevozhay D, Singh M, Schill A, Boerner P, Aglyamov S, Sokolov K, Larin KV. Nanobomb optical coherence elastography in multilayered phantoms. Biomed Opt Express 14(11):5670-5681, 2023. e-Pub 2023. PMID: 38021113.
- Kim CS, Nevozhay D, Aburto RR, Pehere A, Pang L, Dillard R, Wang Z, Smith C, Mathieu KB, Zhang M, Hazle JD, Bast RC, Sokolov K. One-Pot, One-Step Synthesis of Drug-Loaded Magnetic Multimicelle Aggregates. Bioconjug Chem 33(5):969-981, 2022. e-Pub 2022. PMID: 35522527.
- Mitcham TM, Nevozhay D, Chen Y, Nguyen LD, Pinton GF, Lai SY, Sokolov KV, Bouchard RR. Effect of Perfluorocarbon Composition on Activation of Phase-Changing Ultrasound Contrast Agents. Med Phys 49(4):2212-2219, 2022. e-Pub 2022. PMID: 35195908.
- Doshi A, Bandey I, Nevozhay D, Varadarajan N, Cirino PC. Design and characterization of a salicylic acid-inducible gene expression system for Jurkat cells. J Biotechnol 346:11-14, 2022. e-Pub 2022. PMID: 35051448.
- Kupczyk P, Simiczyjew A, Marczuk J, Dratkiewicz E, Beberok A, Rok J, Pieniazek M, Biecek P, Nevozhay D, Slowikowski B, Chodaczek G, Wrzesniok D, Nowak D, Donizy P. PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma-A Clinical and an In Vitro Study. Cells 10(2):1-21, 2021. e-Pub 2021. PMID: 33572647.
- Boerner P, Nevozhay D, Hatamimoslehabadi M, Chawla HS, Zvietcovich F, Aglyamov S, Larin KV, Sokolov KV. Repetitive optical coherence elastography measurements with blinking nanobombs. Biomed Opt Express 11(11):6659-6673, 2020. e-Pub 2020. PMID: 33282515.
- Nevozhay D, Weiger M, Friedl P, Sokolov KV. Spatiotemporally controlled nano-sized third harmonic generation agents. Biomed Opt Express 10(7):3301-3316, 2019. e-Pub 2019. PMID: 31360600.
- Liu CH, Nevozhay D, Zhang H, Das S, Schill A, Singh M, Aglyamov S, Sokolov KV, Larin KV. Longitudinal elastic wave imaging using nanobomb optical coherence elastography. Opt Lett 44(12):3162-3165, 2019. e-Pub 2019. PMID: 31199406.
- Farquhar KS, Charlebois DA, Szenk M, Cohen J, Nevozhay D, Balázsi G. Role of network-mediated stochasticity in mammalian drug resistance. Nat Commun 10(1):2766, 2019. e-Pub 2019. PMID: 31235692.
- Liu CH, Nevozhay D, Schill A, Singh M, Das S, Nair A, Han Z, Aglyamov S, Larin KV, Sokolov KV. Nanobomb optical coherence elastography. Opt Lett 43(9):2006-2009, 2018. e-Pub 2018. PMID: 29714732.
- Kupczyk P, Reich A, Gajda M, Holysz M, Wysokinska E, Paprocka M, Nevozhay D, Chodaczek G, Jagodzinski PP, Ziólkowski P, Szepietowski JC. UCHL1/PGP 9.5 Dynamic in Neuro-Immune-Cutaneous Milieu: Focusing on Axonal Nerve Terminals and Epidermal Keratinocytes in Psoriatic Itch. Biomed Res Int 2018:7489316, 2018. e-Pub 2018. PMID: 30148172.
- Kupczyk P, Reich A, Holysz M, Gajda M, Wysokinska E, Kobuszewska A, Nevozhay D, Nowakowska B, Strzadala L, Jagodzinski PP, Szepietowski JC. Opioid Receptors in Psoriatic Skin: Relationship with Itch. Acta Derm Venereol 97(5):564-570, 2017. e-Pub 2017. PMID: 27958613.
- Bodi Z, Farkas Z, Nevozhay D, Kalapis D, Lazar V, Csorgo B, Nyerges A, Szamecz B, Fekete G, Papp B, Araujo H, Oliveira JL, Moura G, Santos MAS, Szekely T Jr, Balazsi G, Pal C. Phenotypic heterogeneity promotes adaptive evolution. PLoS Biol 15(5):e2000644, 2017. e-Pub 2017. PMID: 28486496.
- Diao J, Charlebois DA, Nevozhay D, Bódi Z, Pál C, Balázsi G. Efflux Pump Control Alters Synthetic Gene Circuit Function. ACS Synth Biol 5(7):619-31, 2016. e-Pub 2016. PMID: 27111147.
- González C, Ray JC, Manhart M, Adams RM, Nevozhay D, Morozov AV, Balázsi G. Stress-response balance drives the evolution of a network module and its host genome. Mol Syst Biol 11(8):827, 2015. e-Pub 2015. PMID: 26324468.
- Chen L, Noorbakhsh J, Adams RM, Samaniego-Evans J, Agollah G, Nevozhay D, Kuzdzal-Fick J, Mehta P, Balazsi G. Two-dimensionality of yeast colony expansion accompanied by pattern formation. PLoS Comput Biol:e1003979, 2014. e-Pub 2014. PMID: 25504059.
- Nevozhay, D. Cheburator software for automatically calculating drug inhibitory concentrations from in vitro screening assays. PLoS One 9(9):e106186, 2014. e-Pub 2014. PMID: 25184280.
- Goszczynski T, Nevozhay D, Wietrzyk J, Omar MS, Boratynski J. The antileukemic activity of modified fibrinogen-methotrexate conjugate. Biochim Biophys Acta 1830(3):2526-2530, 2013. e-Pub 2013. PMID: 23168301.
- Nevozhay D, Zal T, Balázsi G. Transferring a synthetic gene circuit from yeast to mammalian cells. Nat Commun 4:1451, 2013. e-Pub 2013. PMID: 23385595.
- Nevozhay D, Adams RM, Van Itallie E, Bennett MR, Balázsi G. Mapping the environmental fitness landscape of a synthetic gene circuit. PLoS Comput Biol 8(4):e1002480, 2012. e-Pub 2012. PMID: 22511863.
- Jagiello M, Kanska U, Nevozhay D, Boratynski J. Synthesis and biological activity of raltitrexed-carrier conjugates. Acta Biochim Pol 57(1):83-7, 2010. e-Pub 2010. PMID: 20349025.
- Szczaurska-Nowak K, Dabrowska K, Celka M, Kurzepa A, Nevozhay D, Wietrzyk J, Switala-Jelen K, Syper D, Pozniak G, Opolski A, Gorski A, Radzikowski C. Antitumor effect of combined treatment of mice with cytostatic agents and bacteriophage T4. Anticancer Res 29(6):2361-70, 2009. e-Pub 2009. PMID: 19528503.
- Nevozhay D, Adams RM, Murphy KF, Josic K, Balazsi G. Negative autoregulation linearizes the dose-response and suppresses the heterogeneity of gene expression. Proc Natl Acad Sci U S A 106(13):5123-8, 2009. e-Pub 2009. PMID: 19279212.
- Wietrzyk J, Nevozhay D, Milczarek M, Filip B, Kutner A. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model. Cancer Chemother Pharmacol 62(5):787-97, 2008. e-Pub 2008. PMID: 18188568.
- Kanska U, Budzynska R, Nevozhay D, Boratynski J. Preparation of mannan-protein conjugates using high-temperature glycation. Biotechnol Appl Biochem 49(Pt 1):57-64, 2008. e-Pub 2008. PMID: 17630955.
- Wietrzyk J, Nevozhay D, Filip B, Milczarek M, Kutner A. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice. Anticancer Res 27(5A):3387-98, 2007. e-Pub 2007. PMID: 17970085.
- Budzynska R, Nevozhay D, Kanska U, Jagiello M, Opolski A, Wietrzyk J, Boratynski J. Antitumor activity of mannan-methotrexate conjugate in vitro and in vivo. Oncol Res 16(9):415-21, 2007. e-Pub 2007. PMID: 18074676.
- Nevozhay D, Budzynska R, Jagiello M, Kanska U, Omar MS, Opolski A, Wietrzyk J, Boratynski J. The effect of the substitution level of some dextran-methotrexate conjugates on their antitumor activity in experimental cancer models. Anticancer Res 26(3A):2179-86, 2006. e-Pub 2006. PMID: 16827162.
- Nevozhay D, Budzynska R, Kanska U, Jagiello M, Omar MS, Boratynski J, Opolski A. Antitumor properties and toxicity of dextran-methotrexate conjugates are dependent on the molecular weight of the carrier. Anticancer Res 26(2A):1135-43, 2006. e-Pub 2006. PMID: 16619515.
- Siwy M, Sek D, Kaczmarczyk B, Jaroszewicz I, Nasulewicz A, Pelczynska M, Nevozhay D, Opolski A. Synthesis and in vitro antileukemic activity of some new 1,3-(oxytetraethylenoxy)cyclotriphosphazene derivatives. J Med Chem 49(2):806-10, 2006. e-Pub 2006. PMID: 16420065.
- Dabrowska K, Opolski A, Wietrzyk J, Nevozhay D, Szczaurska K, Switala-Jelen K, Boratynski J, Gorski A. Activity of bacteriophages in murine tumor models depends on the route of phage administration. Oncol Res 15(4):183-7, 2005. e-Pub 2005. PMID: 17822278.
- Pelczynska M, Wietrzyk J, Jaroszewicz I, Nevozhay D, Switalska M, Kutner A, Zabel M, Opolski A. Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics. Anticancer Res 25(3B):2235-40, 2005. e-Pub 2005. PMID: 16158969.
- Kanska U, Omar MS, Budzynska R, Nevozhay D, Jagiello M, Opolski A, Boratynski J. Antileukemic activity of glycated fibrinogen-methotrexate conjugates. Anticancer Res 25(3B):2229-34, 2005. e-Pub 2005. PMID: 16158968.
- Nawrocka W, Szutuba B, Liszkiewicz H, Kowalska MW, Wietrzyk J, Nevozhay D, Opolski A. Synthesis and antiproliferative activity in vitro of new 2-aminobenzimidazole. Polish J Chem 79:709-716, 2005. e-Pub 2005.
- Nevozhay D, Dyall CR, Mitcham TM, Chen Y, Nguyen LD, Pinton GF, Lai SY, Bouchard RR, Sokolov KV. Optimization of nanosized contrast agents for ultrasound imaging. SPIE Photonics West.
- Haghighat Mesbahi A, Sokolov KV, Nevozhay D. Development of efficient immunotherapeutic cell labeling probes through optimized perfluorocarbon nanodroplets (PFC-NDs) coated by layer-by-layer (LbL) self-assembly: an experimental and machine learning (ML) approach. SPIE Photonics West.
- Tsitovich PB, Hatami M, Singh M, Montero K, Nevozhay D, Schill AW, Larin KV, Sokolov KV. Perfluorocarbon-modified dyes for optical coherence elastography. SPIE Photonics West.
- Hatami M, Mendieta M, Singh M, Fard SS, Dehshiri M, Schill AW, Nevozhay D, Aglyamov SR, Ozpolat B, Sokolov KV, Akay M, Larin KV. Mechanobiology of glioblastoma spheroids: evaluation using nanobomb optical coherence elastography and Brillouin microscopy. SPIE Photonics West.
Invited Articles
- Schuemann J, Bagley AF, Berbeco R, Bromma K, Butterworth KT, Byrne HL, Chithrani BD, Cho SH, Cook JR, Favaudon V, Gholami YH, Gargioni E, Hainfeld JF, Hespeels F, Heuskin AC, Ibeh UM, Kuncic Z, Kunjachan S, Lacombe S, Lucas S, Lux F, McMahon S, Nevozhay D, Ngwa W, Payne JD, Penninckx S, Porcel E, Prise KM, Rabus H, Ridwan SM, Rudek B, Sanche L, Singh B, Smilowitz HM, Sokolov KV, Sridhar S, Stanishevskiy Y, Sung W, Tillement O, Virani N, Yantasee W, Krishnan S. Roadmap for metal nanoparticles in radiation therapy: current status, translational challenges, and future directions. Phys Med Biol 65(21):21RM02, 2020. e-Pub 2020. PMID: 32380492.
Other Articles
- Nevozhay D, Kanska U, Budzynska R, Boratynski J [Current status of research on conjugates and related drug delivery systems in the treatment of cancer and other diseases]. Postepy Hig Med Dosw (Online) 61:350-60, 2007. PMID: 17554238.
- Nevozhay D, Opolski A Key factors in experimental mouse hematopoietic stem cell transplantation. Arch Immunol Ther Exp (Warsz) 54(4):253-69, 2006. PMID: 16868724.
Abstracts
- Martinez G, Xu Z, Nevozhay D, Harlan CJ, Walker CM, Michel KA, King T, Que E, Sokolov K, Bankson JA. Initial sensitivity evaluation of a new 19F nanoformulation at 3 Tesla using a novel human head coil, 2023. e-Pub 2023.
- Nevozhay D, Tsitovich P, Sokolov K. Studies on Phase-change Nanodroplets for Biomedical Imaging, 2023. e-Pub 2023.
- Tsitovich PB, Hatamimoslehabadi M, Nevozhay D, Han S, Schill AW, Larin KV, Sokolov KV. Perfluorocarbon-modified Dyes to Enhance Activatable Strategies in Cancer Imaging and Therapy, 2022. e-Pub 2022.
- Nevozhay D, Boerner P, Hatamimoslehabadi M, Chawla HS, Zvietcovich F, Aglyamov S, Larin KV, Sokolov KV. Optical Coherence Elastography with Phase-Changing Perfluorocarbon Nanodroplets, 2022. e-Pub 2022.
- Nevozhay D, Mitcham T, Chen Y, Nguyen L, Pinton G, Lai S, Sokolov K, Bouchard R. Effect of perfluorocarbon composition on activation of phase-changing ultrasound contrast agents, 2022. e-Pub 2022.
- Wood C, Han S, Nevozhay D, Meyer J, Rauch G, Cook J, Sokolov K, Bouchard R. Quantitative Photoacoustic Imaging with PAtrace to Assess Treatment Response in a Preclinical Model of Breast Cancer, 2022. e-Pub 2022.
- Wood C, Han S, Nevozhay D, Meyer J, Rauch G, Cook J, Sokolov K, Bouchard R. Noninvasive quantitation of EGFR-targeted PAtrace with photoacoustic imaging to assess treatment response in a preclinical model of breast cancer. Proceedings of the 2022 IEEE International Ultrasonics Symposium, 2022. e-Pub 2022.
- Mitcham TM, Nevozhay D, Chen Y, Kulp A, Nguyen L, Lai S, Sokolov K, Bouchard R. In vivo Imaging and Activation of Perfluorohexane Nanodroplets with High-Frequency Ultrasound. Proceedings of the 2021 IEEE Ultrasonics Symposium, 2021. e-Pub 2021.
- Mitcham TM, Nevozhay D, Lee S, Lai S, Sokolov K, Bouchard R. Optimization of High-Frequency-Ultrasound Imaging and Activation of High Boiling Point Activatable Perfluorocarbon Nanodroplets in a Tissue-Mimicking Phantom. Proceedings of the 2020 IEEE Ultrasonics Symposium, 2020. e-Pub 2020.
- Mitcham TM, Nevozhay D, Schwartz-Duval A, Lai S, Sokolov K, Bouchard R. High-Frequency Ultrasound Imaging of Targeted, Acoustically Activated High-Contrast Perfluorocarbon Nanodroplets, Houston, TX, USA, 2020. e-Pub 2020.
- Mitcham TM, Nevozhay D, Lai S, Sokolov K, Bouchard R. Nonlinear Ultrasound Imaging of Phase-Change Perfluorocarbon Nanodroplets Activated by High-Frequency Ultrasound in a Tissue-Mimicking Environment. American Association of Physicists in Medicine 61st Annual Meeting and Exhibition, San Antonio, TX, 2019. e-Pub 2019.
- Liu CH, Nevozhay D, Das S, Schill A, Singh M, Nair A, Sokolov KV, Larin KV. Longitudinal elastic wave imaging using nanobomb optical coherence elastography, Optical Coherence Tomography and Coherence Domain Optical Methods in Biomedicine, Photonic West 2019. San Francisco, CA, USA, 2019. e-Pub 2019.
- Mitcham TM, Nevozhay D, Vilardo C, Lai S, Sokolov K, Bouchard R. High-frequency molecular ultrasound imaging using targeted phase-change nanodroplets. Kobe, Japan. Proceedings of the 2018 IEEE Ultrasonics Symposium, 2018. e-Pub 2018.
- Mitcham TM, Nevozhay D, Vilardo C, Lai S, Sokolov K, Bouchard R. Ultrasound Activatable Nanodroplets Targeted to EGFR for Molecular Imaging with High-Frequency Ultrasound. American Association of Physicists in Medicine 60th Annual Meeting and Exhibition. Nashville, TN, 2018. e-Pub 2018.
- Mitcham T, Nevozhay D, Lai S, Sokolov K, Bouchard R. Ultrasound activatable nanodroplets targeted to EGFR for molecular imaging with high-frequency ultrasound. 60th Annual Meeting of American Association of Physicists in Medicine. Nashville, TN, USA, 2018. e-Pub 2018.
- Farquhar KS, Charlebois DA, Szenk M, Nevozhay D, Balazsi G. Role of Stochasticity in Mammalian Drug Resistance. The 12th q-Bio Conference. Houston, TX, USA, 2018. e-Pub 2018.
- Liu CH, Nevozhay D, Das S, Schill A, Singh M, Nair A, Sokolov KV, Larin KV. Longitudinal shear wave imaging using nanobomb optical coherence elastography. Gordon research conference: lasers in medicine and biology. Lewiston, ME, USA, 2018. e-Pub 2018.
- Yang J, Igoshin O, Nevozhay D, St-Pierre F. Synthetic gene circuits with tunable expression level and dosage compensation for mammalian cells. The 12th q-Bio Conference. Houston, TX, USA, 2018. e-Pub 2018.
- Liu CH, Nevozhay D, Sokolov KV, Larin KV. Tissue biomechanics with nanobomb optical coherence elastography. Biophotonics congress: biomedical optics. Hollywood, FL, USA, 2018. e-Pub 2018.
- Liu CH, Schill A, Das S, Nevozhay D, Singh M, Nguyen J, Goh M, Nair A, Sokolov KV, Larin KV. Line-field low coherence holography for ultra-fast assessment of tissue biomechanical properties. SPIE Photonics West: Optical Coherence Tomography and Coherence Domain Optical Methods in Biomedicine XXIII. San Francisco, CA, USA, 2018. e-Pub 2018.
- Liu CH, Schill A, Das S, Nevozhay D, Singh M, Nair A, Han Z, Sokolov KV, Larin KV. All-optical low coherence holography using dye nanoparticles. SPIE Photonics west: Optical Elastography and Tissue Biomechanics VI. San Francisco, CA, USA, 2018. e-Pub 2018.
- Farquhar KS, Charlebois DA, Nevozhay D, Balazsi G. Role of Stochasticity in Mammalian Drug Resistance. Mammalian Synthetic Biology Workshop 4.0. Boston, MA, USA, 2017. e-Pub 2017.
- Farquhar KS, Nevozhay D, Balazsi G. Role of Stochasticity in Mammalian Drug Resistance. Mammalian Synthetic Biology Workshop 3.0. Boston, MA, USA, 2016. e-Pub 2016.
- Goncharov NV, Nevozhay D, Isaeva MP. Construction and expression of YPM-TM fusion protein based on Yersinia pseudotuberculosis superantigen. The 2nd International Symposium on Life Sciences. Vladivostok, Russia, 2013. e-Pub 2013.
- Nevozhay D, Zal T, Balazsi G. Transferring a synthetic gene circuit from yeast to mammalian cells. Mammalian Synthetic Biology Workshop. Boston, USA, 2013. e-Pub 2013.
- Bódi Z, Nevozhay D, Szamecz B, Farkas Z, Balázsi G, Pál C. Phenotypic heterogeneity promotes evolutionary adaptation. Hungarian Molecular Life Sciences 2013. Siófok, Hungary, 2013. e-Pub 2013.
- Nevozhay D, Zal T, Balazsi G. Transferring a synthetic gene circuit from yeast to mammalian cells. Computational and Theoretical Biology Symposium. Houston, USA, 2012. e-Pub 2012.
- Nevozhay D, Zal T, Balazsi G. Translational synthetic biology: From yeast to mammalian cells. The Fifth International Meeting on Synthetic Biology (SB5.0). Stanford, USA, 2011. e-Pub 2011.
- Adams RM, Nevozhay D, Van Itallie E, Bennett MR, Balazsi G. The effects of nongenetic memory on population level sensitivity to stress. American Physical Society Annual Meeting. Dallas, USA, 2011. e-Pub 2011.
- Nevozhay D, Adams RM, Van Itallie E, Bennett MR, Balazsi G. Population-level control of gene expression. From Networks to Pattern Formation Symposium. Houston, USA, 2010. e-Pub 2010.
- Boratyński J, Omar MS, Nevozhay D, Kańska U, Goszczyński T, Ciekot J, Wietrzyk J. Antitumor activity of carrier-methotrexate conjugates. The Seventh Multidisciplinary Conference on Drug Research. Zakopane, Poland:13, 2010. e-Pub 2010.
- Nevozhay D, Adams RM, Balazsi G. Decoupling cellular memory from other gene expression characteristics. Computational and Theoretical Biology Symposium. Houston, USA. Proceedings book, 2009. e-Pub 2009.
- Nevozhay D, Adams RM, Murphy KF, Kresimir J, Balazsi G. Precise regulation of gene expression by negative feedback. 19th Keck Center Annual Research Conference. Houston, USA. Proceedings book:91, 2009. e-Pub 2009.
- Nevozhay D, Adams RM, Murphy KF, Kresimir J, G: B. Precise regulation of gene expression by negative feedback. Trainee Research Day. Houston, USA. Proceedings book, 2009. e-Pub 2009.
- Nevozhay D, Adams RM, Murphy KF, Balazsi G. The effect of negative feedback strength on gene expression noise. Systems Biology of Cancer. Houston, USA. Proceedings book:25, 2008. e-Pub 2008.
- Nevozhay D, Adams RM, Murphy KF, Balazsi G. The effect of negative feedback strength on gene expression noise. The 2nd q-Bio Conference on Cellular Information Processing. Santa Fe, USA. Proceedings book:36, 2008. e-Pub 2008.
- Budzyńska R, Nevozhay D, Kańska U, Jagiełło M, Opolski A, Wietrzyk J, Boratyński J. Antitumor activity of mannan–methotrexate conjugate in vitro and in vivo. XIth Gliwice Scientific Meeting. Gliwice, Poland. Proceedings book:56, 2007. e-Pub 2007.
- Bączkowski K, Nevozhay D, Kiraga J, Biecek P, Mackiewicz P, S: C. Generation of the long open reading frames by different genes in the prokaryote genomes. II Polish Congress of Genetics. Warsaw, Poland:282-283, 2007. e-Pub 2007.
- Nevozhay D, Budzyńska R, Kańska U, Wietrzyk J, Boratyński J. Improved antileukemic effect of methotrexate coupled with dextran in mouse model of leukemia. 5th International Symposium on targeted anticancer therapies. Amsterdam, The Netherlands:302, 2007. e-Pub 2007.
- Świtalska M, Wietrzyk J Nevozhay D, Grynkiewicz G. Influence of new analogs and complexes of genistein on the expression of alphavbeta3 integrins on the A498 cell line. 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. Prague, Czech Republic 4(12):158, 2006. e-Pub 2006.
- Nevozhay D, Budzyńska R, Kańska U, Wietrzyk J, J: B. Improved antitumor effect of dextran-methotrexate conjugate in the mouse experimental model of leukemia [in Russian]. The 10th Russian Oncological Congress. Moscow, Russia:238, 2006. e-Pub 2006.
- Boratyński J, Opolski A, Kańska U, Jagiełło M, Budzyńska R, Nevozhay D, Omar MS, Wietrzyk J, Goszczyński T. Antitumor activity of carrier-methotrexate conjugates. Xth Gliwice Scientific Meeting. Gliwice, Poland, 2006. e-Pub 2006.
- Nevozhay D, Omar M, Budzyńska R, Kańska U, Wietrzyk J, Opolski A, J: B. Antitumor activity of protein-methotrexate conjugates in experimental mouse leukemia model. II Congress of Polish Oncology, Poznań, Poland:152, 2006. e-Pub 2006.
- Szczaurska-Nowak K, Celka M, Dąbrowska K, Nasulewicz A, Nevozhay D, Wietrzyk J, Opolski A, Górski A, Radzikowski C. The antimetastatic effect of bacteriophage T4 administrated in combined treatment with PRI-2191 in mice with B16 melanoma. II Congress of Polish Oncology, Poznań, Poland:148, 2006. e-Pub 2006.
- Nevozhay D, Wietrzyk J, Opolski A. Software package for computer analysis of data from in vitro anticancer screening studies. The 1st International Conference on Mathematical Biology and Bioinformatics. Pushchino, Russia:218, 2006. e-Pub 2006.
- Nevozhay D, Kupczyk P, Budzynska R, Nasulewicz A, Szczaurska-Nowak K, Wietrzyk J. Chemotherapy-based model of mouse graft-versus-host disease. Laboratory Animals in Breeding and Research. Gdańsk, Poland:7, 2006. e-Pub 2006.
- Szczaurska K, Dąbrowska K, Celka M, Kurzępa A, Nevozhay D, Wietrzyk J, Świtała Jeleń K, Syper D, Opolski A, A: G. The antimetastatic effect of bacteriophage T4 administered in combined treatment with selected cytostatics in mice with B16 melanoma. The Fifth Multidisciplinary Conference on Drug Research. Darłówko Wschodnie, Poland:40, 2006. e-Pub 2006.
- Nevozhay D, Budzyńska R, Omar MS, Opolski A, Boratyński J. Conjugates of methotrexate and dextrans in mouse leukemia model with multiple dose schedule. The Fifth Multidisciplinary Conference on Drug Research. Darłówko Wschodnie, Poland:40, 2006. e-Pub 2006.
- Budzyńska R, Nevozhay D, Omar MS, Opolski A, Boratyński J. Antitumor activity of mannan-methotrexate conjugate in vitro and in vivo. 4th International Symposium on targeted anticancer therapies. Amsterdam, The Netherlands. Proceedings book:217, 2006. e-Pub 2006.
- Wietrzyk J, Nevozhay D, Kutner A, Opolski A. Toxicity and antitumor activity of vitamin D analogs in combined treatment of experimental mammary cancer. 4th European School of Hematology Euroconference on Animal Models of Human Malignancies and Biotherapies. Budapest, Hungary. Proceedings Book, 2005. e-Pub 2005.
- Nevozhay D, Budzyńska R, Omar MS, Boratyński J, Opolski A. Antileukemic activity and toxicity of dextran-methotrexate conjugates in comparison with free parental drug. 4th European School of Hematology Euroconference on Animal Models of Human Malignancies and Biotherapies. Budapest, Hungary. Proceedings Book:8, 2005. e-Pub 2005.
- Nevozhay D, Dąbrowska K, Świtała-Jeleń K, Szczaurska K, Godlewska J, Nasulewicz A, Wietrzyk J, Pełczyńska M, Opolski A. Busulfan induced myeloablation in the mouse models of bone marrow transplantation with different degrees of histoincompatibility. 10th Congress of the European Hematology Association. Stockholm, Sweden:348, 2005. e-Pub 2005.
- Nevozhay D, Budzyńska R, Omar MS, Boratyński J, Opolski A. In vitro cytotoxicity of dextran-methotrexate conjugates is dependent on the molecular weight of the carrier used. 4th Joint Meeting on Medicinal Chemistry. Vienna, Austria. Proceedings Book:91, 2005. e-Pub 2005.
- Nevozhay D, Opolski A. Software development for large-scale in vitro screening of prospective anticancer compounds. Medical physics and new technologies in medicine, Vladivostok, Russia. Proceedings Book:96-97, 2005. e-Pub 2005.
- Pełczyńska M, Maciejewska M, Nevozhay D, Kutner A, Opolski A. New vitamin D analogs (PRI-1906 and PRI-1907) and their antiproliferative activity in vitro in single or combined with doxorubicin treatment. 3rd International Symposium on targeted anticancer therapies. Amsterdam, The Netherlands:iii32, 2005. e-Pub 2005.
- Jagiełło M, Budzyńska R, Nevozhay D, Omar MS, Boratyński J, A: O. The chemical properties and cytotoxicity in vitro of raltitrexed-carrier conjugates. 13th AEK/AIO Cancer Congress, Würzburg, Germany:49-50, 2005. e-Pub 2005.
- Budzyńska R, Nevozhay D, Omar MS, Jagiełło M, Boratyński J, Opolski A. Cytotoxic activity in vitro of dextran-methotrexate conjugates. 13th AEK/AIO Cancer Congress, Würzburg, Germany:42, 2005. e-Pub 2005.
- Nevozhay D, Budzyńska R, Omar MS, Boratyński J, A: O. Comparison of antitumor activity and toxicity of different methotrexate conjugates coupled with dextran macromolecules. 3rd International Symposium on targeted anticancer therapies. Amsterdam, The Netherlands 3:iii37, 2005. e-Pub 2005.
- Weidlich I, Nevozhay D, Opolski A, Sobiak S. Nitroimidazole derivatives as a new class of anticancer compounds. 229th American Chemical Society National Meeting, San Diego, USA. Proceedings CD:MEDI 422, 2005. e-Pub 2005.
- Nevozhay D, Budzyńska R, Omar MS, Jagiełło M, Boratyński J, A: O. Antitumor activity and toxicity of several dextran-methotrexate conjugates with different levels of substitution. 13th AEK/AIO Cancer Congress, Würzburg, Germany:42, 2005. e-Pub 2005.
- Nevozhay D, Omar MS, Budzynska R, Jagiello M, Kanska U, Opolski A, J: B. Conjugation of methotrexate and raltitrexed (tomudex) with different carrier macromolecules as a way of improvement of their antitumor effect. 18th Meeting of the European Association for Cancer Research. Innsbruck, Austria. Proceedings Book:319, 2004. e-Pub 2004.
- Nawrocka W, Liszkiewicz H, Wietrzyk J, Nevozhay D, Opolski A. Synthesis and antiproliferative activity in vitro of pyrimido[1,2-a]-benzimidazole derivatives. The Fourth Multidisciplinary Conference on Drug Research. Gdańsk-Sobieszewo, Poland:P45, 2004. e-Pub 2004.
- Kańska U, Omar MS, Budzyńska R, Nevozhay D, Jagiełło M, Opolski A, Boratyński J. The chemical and biochemical properties and anti-leukemia activity of methotrexate-glycated fibrinogen conjugates. The Fourth Multidisciplinary Conference on Drug Research. Gdańsk-Sobieszewo, Poland:P95, 2004. e-Pub 2004.
- Nawrocka W, Liszkiewicz H, Wietrzyk J, Nevozhay D, Opolski A. Synthesis and antiproliferative activity in vitro of new 2-aminobenzimidazole derivatives. The Fourth Multidisciplinary Conference on Drug Research. Gdańsk-Sobieszewo, Poland:P46, 2004. e-Pub 2004.
- Nevozhay D, Budzyńska R, Omar MS, Opolski A, J: B. Antitumor activity of dextran-methotrexate conjugate. The Fourth Multidisciplinary Conference on Drug Research. Gdańsk-Sobieszewo, Poland:P120, 2004. e-Pub 2004.
- Nevozhay D, Omar MS, Nasulewicz A, Kańska U, Wietrzyk J, Opolski A, Boratyński J. Antitumor activity of native and glycated fibrinogen-methotrexate conjugates. Current Achievements in Oncology. Poznan, Poland. Rept. Pract. Oncol. Radiother. 8 (Suppl.2):S327-S328, 2003. e-Pub 2003.
- Nevozhay D, Tsitovich P, Jeter C, Friedl P, Bouchard R, Sokolov KV. Phase-change perfluorocarbon nanodroplets for imaging and therapy. Gordon Research Conference, Cancer Nanotechnology.
- Tsitovich PB, Hatamimoslehabadi M, Nevozhay D, Schill AW, Larin KV, Sokolov KV. Perfluorocarbon-modified dyes to enhance activatable strategies in cancer imaging. Gordon Research Conference, Cancer Nanotechnology.
- Nevozhay D, Hatami M, Boerner P, Singh M, Schill A, Chawla HS, Zvietcovich F, Aglyamov S, Larin KV, Sokolov KV. Imaging tissue biomechanics using optical coherence elastography with blinking nanobombs. Gordon Research Conference, Cancer Nanotechnology.
- Nevozhay D, Mitcham TM, Chen Y, Lai SY, Bouchard RR, Sokolov KV. Effect of lipid composition on activation potential of phase-shift ultrasound contrast agents. 65th Annual Meeting of the American Association of Physicists in Medicine.
- Hatami M, Nevozhay D, Singh M, Schill AW, Boerner P, Sokolov KV, Larin KV. Nanobomb-assisted layer-specific optical coherence elastography. Optical Elastography and Tissue Biomechanics XI / SPIE Photonics West.
- Dyall CR, Nevozhay D, Mitcham TM, Chen Y, Lai S, Sokolov K, Bouchard RR. An Adaptive Ultrasound Sequence for Activation and Monitoring of Phase-Changing Nanodroplets. Ultrasonic Imaging and Tissue Characterization Symposium.
- Mesbahi AH, Nevozhay D, Sokolov KV. Engineered Perfluorocarbon (PFC) based Nanodroplets (NDs) for affective labeling of immunotherapeutic cells. Trainee Research Day.
- Nevozhay D, Cook JR, Wu C, Emelianov SY, Sokolov AK. Accurate CTC Enumeration via Co-Registered Photoacoustic and Optical Microscopy with Computational Image Processing. Harrington Symposium.
- Nevozhay D, Hatami M, Singh M, Schill A, Boerner P, Aglyamov S, Larin KV, Sokolov KV. High resolution nanobomb optical coherence elastography in multilayered phantoms and brain tissue. Gordon Research Conference, Multiscale Mechanochemistry and Mechanobiology.
- Dyall C, Nevozhay D, Mitcham TM, Chen Y, Lai S, Sokolov K, Bouchard RR. Optimized and Adaptive High Frame-Rate Ultrasound Imaging of Perfluorocarbon Nanodroplet Activation and Recondensation. IEEE International Ultrasonics Symposium.
- Sehl OC, Yang Y, Anjier AR, Nevozhay D, Cheng D, Guo K, Fellows B, Mohtasebzadeh AR, Mason EE, Sanders T, Kim P, Trease D, Koul D, Goodwill PW, Sokolov K, Wintermark M, Gordon N, Greve JM, Gopalakrishnan V. Preclinical and clinical-scale magnetic particle imaging of NK cells: in vitro and ex vivo demonstration of cellular sensitivity, resolution, and quantification. World Molecular Imaging Congress.
Book Chapters
- Nevozhay, D, Bouchard, RR, Sokolov, KV. Photoacoustic Imaging with Plasmonic Nanoparticles. In: World Scientific Reference on Plasmonic Nanomaterials: Principles, Design and Bio-applications, 325-370, 2022.
- Charlebois DA, Diao J, Nevozhay D, Balazsi G. Negative Regulation Gene Circuits for Efflux Pump Control. In: Methods Mol Biol, 25-43, 2018.
- Nevozhay D, Adams RM, Balazsi G. Linearizer gene circuits with negative feedback regulation. In: Yeast Genetic Networks: Methods and Protocols, 81-100, 2011.
- Siwy M, Sek D, Kaczmarczyk B, Jaroszewicz I, Nasulewicz A, Pelczynska M, Nevozhay D, Opolski A. [Macrocyclic cyclophosphazene derivatives with cytostatic activity]. In: [Modification of Polymers], 623-626, 2005.
Selected Presentations & Talks
Local Presentations
- 2017. Using synthetic biology to develop gene expression system. Invited. Stony Brook University. Stony Brook, NY, US.
- 2013. Transferring a synthetic gene circuit from yeast to human cells. Invited. University of Houston. Houston, TX, US.
- 2011. The effects of nongenetic memory on population level sensitivity to stress. Invited. University of Texas-Houston Medical School. Houston, TX, US.
- 2010. Cellular memory and possible stress-induced mutations in yeast cells. Invited. Baylor College of Medicine. Houston, TX, US.
- 2010. Synthetic biology: biology meets engineering. Invited. Rice University. Houston, TX, US.
- 2008. Gene expression noise and feedback regulation in transcriptional cascades. Invited. Rice University. Houston, TX, US.
National Presentations
- 2025. Optimization of nanosized contrast agents for ultrasound imaging. Conference. SPIE Photonics West. San Francisco, CA, US.
- 2016. Developing systems for precise gene expression dosage in lower and higher eukaryotes. Invited. American Chemical Society SWRM. Galveston, TX, US.
- 2012. Decreasing the stochasticity of mammalian gene expression by a synthetic gene circuit. Conference. American Physical Society Annual Meeting. Boston, MA, US.
- 2011. Population-level control of gene expression. Conference. American Physical Society Annual Meeting. Dallas, TX, US.
- 2009. Precise regulation of gene expression by negative feedback. Conference. The 3rd q-bio Conference on Cellular Information Processing. Santa Fe, NM, US.
International Presentations
- 2023. Effect of perfluorocarbon composition on activation of phase-changing ultrasound contrast agents. Invited. Ultrasonics. Caparica, PT.
- 2012. Synthetic biology is the novel genetic engineering. Invited. Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of Russian Academy of Sciences. Vladivostok, RU.
- 2012. Synthetic biology: genetic engineering for the 21st century. Invited. Institute of Immunology and Experimental Therapy. Wroclaw, PL.
- 2005. Effect of calcitriol administration on survival and chimerism after allogeneic BMT in mice. Conference. 3rd Annual Meeting of the European Stem Cell Therapeutics Excellence Centre (STEC). Krakow, PL.
- 2005. The biological properties of different dextran-methotrexate conjugates in tumor models in vitro and in vivo. Conference. The VIth Russian Oncological Congress. Rostov-on-Don, RU.
- 2005. The effect of calcitriol analogue on beta3 integrin-positive tumors. Conference. 2nd Symposium on Vitamin D Analogs in Cancer Prevention and Therapy. Lubeck, DE.
Grant & Contract Support
Date: | 2025 - 2027 |
Title: | MUC16 Imaging for Early Diagnosis of Ovarian Cancer |
Funding Source: | Department of Defense |
Role: | PI |
ID: | GRANT14224761 |
Date: | 2025 - 2027 |
Title: | Ultrasound-guided cancer immunotherapy with targeted nanodroplets |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 1R21CA304638-01 |
Date: | 2025 - 2028 |
Title: | Cancer Prevention Research Institute of Texas (CPRIT |
Funding Source: | Cancer Prevention Research Institute of Texas (CPRIT) |
Role: | Co-I |
ID: | RP250279 |
Date: | 2024 - 2026 |
Title: | Quantitative noncontact imaging of cellular mechanotransduction |
Funding Source: | NIH/NCI |
Role: | Research Assistant Professor |
ID: | 1R21CA297102-01 |
Date: | 2024 - 2026 |
Title: | Perfluorocarbon Nanoparticles 19F MRI to Characterize Space Radiation Induced Acute Pro-Inflamm Response & Anti-Inflamm Effects of Radiation Mitigating Thrombin Peptide to Extend Healthy Life in Space |
Funding Source: | Radiological Society of North America (RSNA) |
Role: | PI |
ID: | RR24‐102 |
Date: | 2024 - 2029 |
Title: | Novel approach to NK cell therapy for recurrent/refractory pediatric medulloblastoma |
Funding Source: | Nevozhay |
Role: | Collaborator |
ID: | 1UG3CA297733-01 |
Date: | 2024 - 2026 |
Title: | Perfluorocarbon Nanoparticles 19F MRI to Characterize Space Radiation Induced Acute Pro-Inflamm Response & Anti-Inflamm Effects of Radiation Mitigating Thrombin Peptide to Extend Healthy Life in Space |
Funding Source: | Radiological Society of North America (RSNA) |
Role: | Mentor |
Date: | 2024 - 2025 |
Title: | Using Perfluorocarbon Nanoparticles 19F MRI to Characterize Space Radiation Induced Acute Pro‐Inflammatory Response and Anti‐Inflammatory Effects of Radiation Mitigating Thrombin Peptide to Extend Healthy Life in Space |
Funding Source: | Radiological Society of North America (RSNA) |
Role: | PI |
ID: | RR24‐102 |
Date: | 2024 - 2029 |
Title: | New approach for osteosarcoma: Enhancing and monitoring NK cell therapy |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 1P01CA275719-01A1 |
Date: | 2024 - 2028 |
Title: | Priming preclinical magnetic particle Imaging (MPI) for brain Tumor NK Cell tracking in Humans (PITCH) |
Funding Source: | NIH/NCI |
Role: | Co-I |
Date: | 2024 - 2026 |
Title: | Phase-change nanodroplets for ultrasound guided cancer immunotherapy |
Funding Source: | NIH/NCI |
Role: | Co-I |
Date: | 2024 - 2029 |
Title: | Clinical trial of NK cells for pediatric 4th ventricle brain tumors with magnetic particle Imaging (MPI) tracking |
Funding Source: | NIH/NCI |
Role: | Collaborator |
Date: | 2024 - 2026 |
Title: | Noncontact biomechanical characterization of cellular mechanotransduction |
Funding Source: | NIH/NCI |
Role: | Assistant Professor |
Date: | 2024 - 2027 |
Title: | Next-generation high-Z nanoparticle radiosensitizers to advance combination cancer therapies |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Co-I |
ID: | RP240156 |
Date: | 2024 - 2026 |
Title: | NK Immunotherapy for DIPG |
Funding Source: | Children's Cancer Research Fund |
Role: | Collaborator |
Date: | 2023 - 2028 |
Title: | Clinical trial of NK cells for pediatric 4th ventricle brain tumors with magnetic particle Imaging (MPI) tracking |
Funding Source: | NIH/NCI |
Role: | Collaborator |
ID: | 1UG3CA283650-01 |
Date: | 2023 - 2024 |
Title: | Preclinical magnetic particle Imaging (MPI) for brain Tumor NK Cell tracking |
Funding Source: | Elsa U. Pardee Foundation |
Role: | Co-I |
ID: | 20546 |
Date: | 2023 - 2025 |
Title: | Noncontact biomechanical characterization of cellular mechanotransduction |
Funding Source: | NIH/NCI |
Role: | Collaborator |
ID: | 1R21CA283430-01 |
Date: | 2023 - 2028 |
Title: | Priming preclinical magnetic particle Imaging (MPI) for brain Tumor NK Cell tracking in Humans (PITCH) |
Funding Source: | NIH/NCI |
Role: | Collaborator |
ID: | 1R01CA281832-01 |
Date: | 2023 - 2026 |
Title: | NK Immunotherapy for DIPG |
Funding Source: | ChadTough Defeat DIPG Foundation |
Role: | Collaborator |
Date: | 2023 - 2025 |
Title: | Hyperpolarized 129Xe MRI for imaging NK cell therapy of lung metastasis |
Funding Source: | NIH/NCI |
Role: | Instructor |
ID: | 5R21CA280799-02 |
Date: | 2023 - 2027 |
Title: | Next-generation high-Z nanoparticle radiosensitizers to advance combination cancer therapies |
Funding Source: | NIH/NCI |
Role: | Instructor |
ID: | 1R01CA274955-01A1 |
Date: | 2022 - 2027 |
Title: | New Approach for Osteosarcoma: Enhancing and Monitoring NK Cell Therapy |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 1P01CA2757190-01 |
Date: | 2022 - 2026 |
Title: | NO TITLE PROVIDED |
Funding Source: | NIH |
Role: | Instructor |
ID: | 1R01CA274955-01 |
Date: | 2022 - 2027 |
Title: | Using Stealth Gold Nanoparticles to Improve Radiation Therapy |
Funding Source: | NIH |
Role: | Co-I |
ID: | 1P01CA257932-01A1 |
Date: | 2022 - 2027 |
Title: | Unraveling dynamic co-evolutions of brain metastasis and the unique brain microenvironment |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 1U54CA261702-01A1 |
Date: | 2022 - 2025 |
Title: | Translatable Molecular Ultrasound Imaging of Cancer Metastasis Using Targeted Phase-change Nanodroplets |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
ID: | RP220379 |
Date: | 2021 - 2026 |
Title: | Unraveling dynamic co-evolutions of brain metastasis and the unique brain microenvironment |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 1U54CA261702-01 |
Date: | 2021 - 2023 |
Title: | Development of fluorinated dyes for deeper tissue photoacoustic imaging with phase changing nanodroplets |
Funding Source: | NIH/NIBIB |
Role: | Collaborator |
ID: | 1R21EB030805-01A1 |
Date: | 2021 - 2026 |
Title: | Stealth nanoscale armored particles for radiosensitization of head and neck tumors |
Funding Source: | NIH/NCI |
Role: | Collaborator |
ID: | 1R01CA264096-01 |
Date: | 2020 - 2025 |
Title: | Shielded gold nanoparticles with greatly improved pharmacokinetics for radiosensitization of head and neck tumors |
Funding Source: | NIH/NIDCR |
Role: | Co-I |
ID: | 1R01DE030017-01A1 |
Date: | 2020 - 2022 |
Title: | Development of antibody-conjugated magnetic liposomal nanoparticles for early detection of ovarian Cancer by magnetic relaxometry |
Funding Source: | Internal- Moonshot |
Role: | Co-I |
Date: | 2020 - 2021 |
Title: | Tumor heterogeneity in immune sensitivity of DIPGs |
Funding Source: | Chance of Life Foundation |
Role: | Co-I |
Date: | 2020 - 2023 |
Title: | High sensitivity 19F MRI for clinically translatable imaging of adoptive NK cell brain tumor therapy |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Instructor |
ID: | RP200223 |
Date: | 2019 - 2022 |
Title: | CAR-NK Adoptive Cell Therapy for Osteosarcoma |
Funding Source: | UTMDACC - MRP |
Role: | Collaborator |
Date: | 2019 - 2023 |
Title: | Neoadjuvant treatment response monitoring of breast cancer with molecular photoacoustic imaging |
Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
Role: | Collaborator |
ID: | RP190131 |
Date: | 2019 - 2022 |
Title: | 3D Imaging of Tumor Mechanobiology Using Nanobomb Optical Coherence Elastography |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 5R21CA231561-02 |
Date: | 2018 - 2021 |
Title: | Targeted Phase-change Nanodroplets for Translatable Molecular Ultrasound Imaging of Micrometastases |
Funding Source: | NIH/NCI |
Role: | Co-I |
ID: | 5R21CA234526-02 |
Date: | 2018 - 2020 |
Title: | MRI imaging of adoptive NK Cell immunotherapy |
Funding Source: | MD Anderson Cancer |
Role: | Research Scientist |
ID: | IRG-Institutional Research Grant |
Date: | 2012 - 2017 |
Title: | K99/R00 Pathway to Independence Award; Development of inducible mammalian systems for precise and dose-dependent regulation of gene expression |
Funding Source: | NIH/NIBIB |
Role: | PI |
ID: | 1K99B015723-01 |
Patient Reviews
CV information above last modified April 25, 2025